IO Biotech, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €53.35M +163.7% -€44.34M -26.2% -83.1% +2.1 pp N/A N/A
    (estimated) €20.23M +∞% -€60.07M -13.0% -296.9% -3.0 pp N/A N/A
    (estimated) €0.00 +NaN% -€69.05M -5.8% N/A N/A N/A
    (estimated) €0.00 +NaN% -€73.27M -10.9% N/A N/A N/A
    €0.00 +NaN% -€82.27M +10.9% N/A -€70.91M +15.2% N/A
    €0.00 +NaN% -€74.16M +20.5% N/A -€61.53M +21.0% N/A
    €0.00 +NaN% -€61.56M +5.3% N/A -€50.86M +45.8% N/A
    €0.00 +NaN% -€58.48M +462.5% N/A -€34.89M +306.7% N/A
    €0.00 +NaN% -€10.40M +12.3% N/A -€8.58M +12.0% N/A
    €0.00 -€9.26M N/A -€7.66M N/A

    Notifications